161 related articles for article (PubMed ID: 31580556)
21. Hepatitis B and C infection: is it a problem in Polish healthcare workers?
Rybacki M; Piekarska A; Wiszniewska M; Walusiak-Skorupa J
Int J Occup Med Environ Health; 2013 Jun; 26(3):430-9. PubMed ID: 23817869
[TBL] [Abstract][Full Text] [Related]
22. Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge.
De Monte A; Courjon J; Anty R; Cua E; Naqvi A; Mondain V; Cottalorda J; Ollier L; Giordanengo V
J Clin Virol; 2016 May; 78():27-30. PubMed ID: 26967675
[TBL] [Abstract][Full Text] [Related]
23. Evidence of sustained reductions in the relative risk of acute hepatitis B and C virus infections, and the increasing burden of hepatitis a virus infection in Egypt: comparison of sentinel acute viral hepatitis surveillance results, 2001-17.
Talaat M; Afifi S; Reaves EJ; Abu Elsood H; El-Gohary A; Refaey S; Hammad R; Abdel Fadeel M; Kandeel A
BMC Infect Dis; 2019 Feb; 19(1):159. PubMed ID: 30764780
[TBL] [Abstract][Full Text] [Related]
24. Molecular epidemiology of hepatitis B, C, D and E viruses among children in Moscow, Russia.
Abe K; Hayakawa E; Sminov AV; Rossina AL; Ding X; Huy TT; Sata T; Uchaikin VF
J Clin Virol; 2004 May; 30(1):57-61. PubMed ID: 15072755
[TBL] [Abstract][Full Text] [Related]
25. [Cure of chronic Hepatitis B and C: vision versus reality].
Boettler T; Thimme R; Neumann-Haefelin C
Dtsch Med Wochenschr; 2015 Jul; 140(14):1056-62. PubMed ID: 26182254
[TBL] [Abstract][Full Text] [Related]
26. Management of hepatitis C virus infection in the Asia-Pacific region: an update.
Lim SG; Aghemo A; Chen PJ; Dan YY; Gane E; Gani R; Gish RG; Guan R; Jia JD; Lim K; Piratvisuth T; Shah S; Shiffman ML; Tacke F; Tan SS; Tanwandee T; Win KM; Yurdaydin C
Lancet Gastroenterol Hepatol; 2017 Jan; 2(1):52-62. PubMed ID: 28404015
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B and hepatitis C in southeast and southern Asia: challenges for governments.
Wait S; Kell E; Hamid S; Muljono DH; Sollano J; Mohamed R; Shah S; Mamun-Al-Mahtab ; Abbas Z; Johnston J; Tanwandee T; Wallace J
Lancet Gastroenterol Hepatol; 2016 Nov; 1(3):248-255. PubMed ID: 28404097
[TBL] [Abstract][Full Text] [Related]
28. Surveillance and epidemiology of hepatitis B and C in Europe - a review.
Rantala M; van de Laar MJ
Euro Surveill; 2008 May; 13(21):. PubMed ID: 18761967
[TBL] [Abstract][Full Text] [Related]
29. What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats.
Ward JW; Hinman AR
Gastroenterology; 2019 Jan; 156(2):297-310. PubMed ID: 30391470
[TBL] [Abstract][Full Text] [Related]
30. Access to hepatitis C treatment for people who inject drugs in low and middle income settings: Evidence from 5 countries in Eastern Europe and Asia.
Luhmann N; Champagnat J; Golovin S; Maistat L; Agustian E; Inaridze I; Myint WM; Butsashvili M; Bouscaillou J
Int J Drug Policy; 2015 Nov; 26(11):1081-7. PubMed ID: 26342273
[TBL] [Abstract][Full Text] [Related]
31. High prevalence of hepatitis B and poor knowledge on hepatitis B and C viral infections among barbers: a cross-sectional study of the Obuasi municipality, Ghana.
Adoba P; Boadu SK; Agbodzakey H; Somuah D; Ephraim RK; Odame EA
BMC Public Health; 2015 Oct; 15():1041. PubMed ID: 26456626
[TBL] [Abstract][Full Text] [Related]
32. Progress towards achieving viral hepatitis B and C elimination in the Asia and Pacific region: Results from modelling and global reporting.
Le LV; Blach S; Rewari B; Chan P; Fuqiang C; Ishikawa N; Sharma M; Mangadan-Konath N; Razavi H; Low-Beer D; Razavi-Shearer D
Liver Int; 2022 Aug; 42(9):1930-1934. PubMed ID: 34894047
[TBL] [Abstract][Full Text] [Related]
33. Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic review.
Papatheodoridis GV; Tsochatzis E; Hardtke S; Wedemeyer H
Liver Int; 2014 Nov; 34(10):1452-63. PubMed ID: 24750532
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial management.
De Vroey B; Moreno C; Laleman W; van Gossum M; Colle I; de Galocsy C; Langlet P; Robaeys G; Orlent H; Michielsen P; Delwaide J; Reynaert H; D'Heygere F; Sprengers D; Bourgeois S; Assene C; Vos B; Brenard R; Adler M; Henrion J; Deltenre P
Eur J Gastroenterol Hepatol; 2013 May; 25(5):613-9. PubMed ID: 23325285
[TBL] [Abstract][Full Text] [Related]
35. Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries.
Ishizaki A; Bouscaillou J; Luhmann N; Liu S; Chua R; Walsh N; Hess S; Ivanova E; Roberts T; Easterbrook P
BMC Infect Dis; 2017 Nov; 17(Suppl 1):696. PubMed ID: 29143609
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B and C status among health care workers in the five main hospitals in eastern Libya.
Elzouki AN; Elgamay SM; Zorgani A; Elahmer O
J Infect Public Health; 2014; 7(6):534-41. PubMed ID: 25151657
[TBL] [Abstract][Full Text] [Related]
37. High rates of hepatitis C virus (HCV) cure using direct-acting antivirals in HIV/HCV-coinfected patients: a real-world perspective.
Hawkins C; Grant J; Ammerman LR; Palella F; Mclaughlin M; Green R; Mcgregor D; Stosor V
J Antimicrob Chemother; 2016 Sep; 71(9):2642-5. PubMed ID: 27330060
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C in Eastern Europe and Central Asia: a survey of epidemiology, treatment access and civil society activity in eleven countries.
Maistat L; Kravchenko N; Reddy A
Hepatol Med Policy; 2017; 2():9. PubMed ID: 30288322
[TBL] [Abstract][Full Text] [Related]
39. Direct-acting antivirals in hepatitis C virus (HCV)-infected and HCV/HIV-coinfected patients: real-life safety and efficacy.
Milazzo L; Lai A; Calvi E; Ronzi P; Micheli V; Binda F; Ridolfo AL; Gervasoni C; Galli M; Antinori S; Sollima S
HIV Med; 2017 Apr; 18(4):284-291. PubMed ID: 27477612
[TBL] [Abstract][Full Text] [Related]
40. Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature.
Fabbri G; Mastrorosa I; Vergori A; Mazzotta V; Pinnetti C; Grisetti S; Zaccarelli M; Ammassari A; Antinori A
BMC Infect Dis; 2017 Mar; 17(1):182. PubMed ID: 28249574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
